Chantix is a prescription medication intended to help people quit smoking. The drug, manufactured by Pfizer, affects receptors in the brain to reduce nicotine cravings. After receiving FDA approval in 2006, however, Chantix was linked to a number of serious and life threatening side effects, including an increased propensity for depression, suicide and abnormal behavior.   By 2007, only two drugs had more reported problems than Chantix.

Chantix Suicide

Soon after the drug’s release, complaints of major side effects including Chantix suicide were filed. As of May 27, 2010, the FDA has reported nearly 500 cases of suicidal thinking and 39 suicides related to Chantix. To prevent further cases of Chantix suicide, the FDA ordered Pfizer to add a black box warning to warn users about dangerous and life- threatening side effects, including suicidal ideations and other psychological problems.

Chantix Suicide and Lawsuits

Many lawsuits against Pfizer relating to Chantix suicide and other side effects have been filed in both state and federal courts.  These lawsuits allege that Pfizer failed to sufficiently research Chantix and failed to provide all relevant information to doctors and users regarding its side effects. Patients with psychiatric disorders or symptoms were excluded from clinical trials, providing potential inaccurate data regarding Chantix side effects.

The first lawsuit relating to Chantix suicide was filed in July 2008 in federal court in Indiana. A man with no history or symptoms of mental illness committed suicide after taking Chantix for a few months.  Multiple Chantix suicide lawsuits have been filed since then around the country.  In October 2009, the U.S. Judicial Panel on Multidistrct Litigation consolidated the Chantix related federal lawsuits before a single court in Alabama. 

Chantix Suicide Lawyer

If you or a loved one have attempted suicide as a result of taking Chantix, contact us today for a free case evaluation.  You may be entitled to financial compensation for your injuries.

Published November 17, 2011 by